Physician

Akhil Sharma, MD

According to 2025 Medicare claims, Akhil Sharma, MD (NPI: 1679849475) practices nephrology in the Detroit-Dearborn-Livonia, MI market, with the plurality of this provider's patient population coming from Wayne, MI. This provider's primary affiliated billing organization is REGENTS OF THE UNIVERSITY OF MICHIGAN (NPI: 1003848144; TIN: 386006309) and primary practice location at 48109-5000. Sharma is affiliated with the CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Sharma's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 287 traditional Medicare patients, billed 735 HCPCS/CPT codes, and received $54,804 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 2,173 prescription claims across 346 beneficiaries totaling $180,318 in drug costs, led by Veltassa (Patiromer Calcium Sorbitex). DME data shows 2,173 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $15,073 and ending at $54,804. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $6,793 to $180,318. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $0 to $0.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	84	185	$15,073
2019	208	445	$34,668
2020	235	719	$59,392
2021	231	668	$52,642
2022	187	486	$39,957
2023	266	665	$55,299
2024	287	735	$54,804

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	19	108	$6,793
2016	13	94	$3,608
2017	15	40	$676
2018	24	65	$7,744
2019	51	111	$10,591
2020	190	930	$94,077
2021	314	2,174	$227,532
2022	331	2,055	$210,095
2023	298	2,324	$236,249
2024	346	2,173	$180,318

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	81	$7,562
2019	49	95	$3,015
2020	189	936	$85,541
2021	273	1,784	$122,160
2022	320	2,219	$112,315
2023	371	2,555	$115,383
2024	393	2,173	$119,471

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	100	117	$108
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	23	26	$84
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	58	172	$84
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	178	218	$72
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	90	100	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Veltassa	Patiromer Calcium Sorbitex	18	540	$21,213
Lokelma	Sodium Zirconium Cyclosilicate	16	582	$18,207
Tacrolimus	Tacrolimus	128	5,409	$13,968
Atovaquone	Atovaquone	17	504	$7,566
Valganciclovir Hcl	Valganciclovir Hcl	33	1,001	$6,271

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7503	Tacrolimus, extended release, (envarsus xr), oral, 0.25 mg	N	13	73	$65,335
J7507	Tacrolimus, immediate release, oral, 1 mg	N	95	543	$12,896
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	92	461	$8,051
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	86	495	$6,268
J7527	Everolimus, oral, 0.25 mg	N	N/R	14	$6,020

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Akhil Sharma, MD?

Tedicare shows public-source Medicare data for Akhil Sharma, MD (NPI 1679849475), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Akhil Sharma, MD have ACO affiliation data?

Akhil Sharma, MD is shown with ACO affiliation data for CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Akhil Sharma, MD?

Akhil Sharma, MD is linked to REGENTS OF THE UNIVERSITY OF MICHIGAN (billing NPI 1003848144) in the available physician profile data.

Does Akhil Sharma, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.